BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
1.670
+0.070 (4.37%)
At close: Jun 26, 2026, 4:00 PM EDT
1.690
+0.020 (1.20%)
After-hours: Jun 26, 2026, 4:10 PM EDT
BeyondSpring Employees
BeyondSpring had 44 employees as of December 31, 2025. The number of employees increased by 4 or 10.00% compared to the previous year.
Employees
44
Change (1Y)
4
Growth (1Y)
10.00%
Revenue / Employee
n/a
Profits / Employee
-$173,682
Market Cap
69.49M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Seres Therapeutics | 66 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| Gain Therapeutics | 21 |
| ImageneBio | 17 |
| Edesa Biotech | 17 |
BYSI News
- 23 days ago - BeyondSpring appoints Min Qiu as CEO, Na Li as CFO - TheFly
- 23 days ago - BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value - GlobeNewsWire
- 25 days ago - BeyondSpring announces updated data from 303 Study - TheFly
- 25 days ago - BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026 - GlobeNewsWire
- 5 weeks ago - BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting - GlobeNewsWire
- 6 weeks ago - BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - BeyondSpring Earnings release: Q1 2026 - Filings
- 6 weeks ago - BeyondSpring Quarterly report: Q1 2026 - Filings